Clinical Trials Logo

Hypersexuality clinical trials

View clinical trials related to Hypersexuality.

Filter by:
  • None
  • Page 1

NCT ID: NCT06408545 Recruiting - Clinical trials for Compulsive Sexual Behavior

Acceptance and Commitment Therapy for Problematic Chemsex

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex. As a pilot study, the intervention will be tested in a small group.

NCT ID: NCT06406296 Not yet recruiting - Clinical trials for Compulsive Sexual Behavior

Effectiveness of ACT for Problematic Chemsex

ChemACT
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of problematic chemsex.

NCT ID: NCT05572372 Completed - Clinical trials for Compulsive Sexual Behavior

Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality

Start date: January 8, 2022
Phase: N/A
Study type: Interventional

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of hypersexuality.

NCT ID: NCT04811807 Not yet recruiting - Parkinson Disease Clinical Trials

Clinical Response of Impulsivity After Brain Stimulation in Parkinson's Disease

CRIPS
Start date: October 2021
Phase:
Study type: Observational [Patient Registry]

The objective of this prospective observational cohort study is to answer the following clinically important questions: 1. In patients with a pre-operative history of ICBs, what is the likelihood of improvement or deterioration in ICBs post-operatively? 2. What is the risk of developing post-operative de novo ICBs after Subthalamic Nucleus DBS (STN DBS)? 3. Which factors are important in predicting changes in ICBs after STN DBS? 4. What is the impact of ICBs on carer's quality of life QoL and burden?

NCT ID: NCT03495414 Completed - Clinical trials for Compulsive Sexual Behavior

Neurobiological Underpinnings to Hypersexual Disorder

Start date: April 1, 2018
Phase:
Study type: Observational

Hypersexual Disorder (HD), sometimes called "sexual addiction", is a disorder with intense sexual desires and psychological preoccupations that lead to out-of-control sexual activities with severe consequences. HD is related to higher risks of HIV infection and an important risk factor for committing sexual crimes. The prevalence of HD is 3-6% of the general population, thus, a significant burden for society. The neurobiological mechanisms behind HD are still unknown, and there is still a great need for causal treatments. This study is aimed at identifying neurobiological and psychological mechanisms underlying HD as a basis for treatment development. The overall goal is to improve mental health, quality of life, diagnosis and treatment options for affected individuals, and to reduce the impact HD can have on society. Patients with HD will be recruited at Karolinska University Hospital in close collaboration between endocrinologists, psychologists, psychiatrists, and brain researchers at Karolinska Institutet. Cases and healthy controls will undergo brain scans (MRI), psychological and blood tests to quantify neurobiological, cognitive, and behavioral aspects of HD. This study is directly integrated into clinical practice, can identify important targets for interventions and factors predicting treatment outcomes. This study is essential for a better understanding of HD, the improvement of treatments, and can have significant impact on the prevention of HIV infections and sexual crimes.